BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24786705)

  • 1. Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria.
    Verzola D; Cappuccino L; D'Amato E; Villaggio B; Gianiorio F; Mij M; Simonato A; Viazzi F; Salvidio G; Garibotto G
    Kidney Int; 2014 Dec; 86(6):1229-43. PubMed ID: 24786705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effects of 1,25-dihydroxyvitamin D3 in monocytes cultured in serum from patients with type 2 diabetes mellitus and diabetic nephropathy with uremia via Toll-like receptor 4 and nuclear factor-κB p65.
    Yang M; Xu J; Yu J; Yang B; Gan H; Li S; Li X
    Mol Med Rep; 2015 Dec; 12(6):8215-22. PubMed ID: 26497229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
    Liu P; Li F; Qiu M; He L
    Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy.
    Jheng HF; Tsai PJ; Chuang YL; Shen YT; Tai TA; Chen WC; Chou CK; Ho LC; Tang MJ; Lai KT; Sung JM; Tsai YS
    Dis Model Mech; 2015 Oct; 8(10):1311-21. PubMed ID: 26398934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy.
    Lin M; Yiu WH; Wu HJ; Chan LY; Leung JC; Au WS; Chan KW; Lai KN; Tang SC
    J Am Soc Nephrol; 2012 Jan; 23(1):86-102. PubMed ID: 22021706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
    Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of LPS on the level of TLR4 and on the expression of NF-κB and Notch1 in monocytes from patients with type 2 diabetic nephropathy].
    Yang M; Gan H; Shen Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jun; 37(6):578-85. PubMed ID: 22772413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy.
    Mezzano S; Aros C; Droguett A; Burgos ME; Ardiles L; Flores C; Schneider H; Ruiz-Ortega M; Egido J
    Nephrol Dial Transplant; 2004 Oct; 19(10):2505-12. PubMed ID: 15280531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
    Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
    Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
    Uehara G; Suzuki D; Toyoda M; Umezono T; Sakai H
    Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular mRNAs in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy.
    Adler SG; Kang SW; Feld S; Cha DR; Barba L; Striker L; Striker G; Riser BL; LaPage J; Nast CC
    Kidney Int; 2001 Dec; 60(6):2330-6. PubMed ID: 11737607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-trans retinoic acid ameliorates inflammatory response mediated by TLR4/NF-κB during initiation of diabetic nephropathy.
    Sierra-Mondragon E; Molina-Jijon E; Namorado-Tonix C; Rodríguez-Muñoz R; Pedraza-Chaverri J; Reyes JL
    J Nutr Biochem; 2018 Oct; 60():47-60. PubMed ID: 30193155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Inhibitory Effect of Rapamycin on Toll Like Receptor 4 and Interleukin 17 in the Early Stage of Rat Diabetic Nephropathy.
    Yu R; Bo H; Villani V; Spencer PJ; Fu P
    Kidney Blood Press Res; 2016; 41(1):55-69. PubMed ID: 26849067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a CCR2 antagonist on macrophages and Toll-like receptor 9 expression in a mouse model of diabetic nephropathy.
    Ito S; Nakashima H; Ishikiriyama T; Nakashima M; Yamagata A; Imakiire T; Kinoshita M; Seki S; Kumagai H; Oshima N
    Am J Physiol Renal Physiol; 2021 Dec; 321(6):F757-F770. PubMed ID: 34719947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
    Ninichuk V; Kulkarni O; Clauss S; Anders H-
    Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes.
    Ladefoged M; Buschard K; Hansen AM
    APMIS; 2013 Jun; 121(6):531-8. PubMed ID: 23134512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lectin-like oxidized LDL receptor-1 (LOX-1) expression in the tubulointerstitial area likely plays an important role in human diabetic nephropathy.
    Yamamoto N; Toyoda M; Abe M; Kobayashi T; Kobayashi K; Kato M; Miyauchi M; Kimura M; Umezono T; Suzuki D
    Intern Med; 2009; 48(4):189-94. PubMed ID: 19218767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of intrarenal product TNF-alpha in the development of glomerular and tubulointerstitial tissues changes in elderly patients with diabetic nephropathy].
    Rakitianskaia IA; Riabov SI; Azanchevskaia SV; Riabova TS; Al-Barbari K; Gurkov AS; Popova VB
    Adv Gerontol; 2013; 26(4):658-65. PubMed ID: 24738256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy.
    Garibotto G; Carta A; Picciotto D; Viazzi F; Verzola D
    J Nephrol; 2017 Dec; 30(6):719-727. PubMed ID: 28933050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.